theweek.com Β·
the prevalence of antidepressants in conflict zones

Topic context
This topic has been covered 398076 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedConflict zones (Iran, Lebanon, Cuba, Russia) show massive demand spikes for antidepressants and sedatives, driven by war, economic crisis, and social unrest. The channel is demand_spike for specific pharmaceuticals, with price gouging (400% in Iran) and prescription bypass. Impact is region-specific (Iran, Lebanon, Cuba, Russia) but global pharma supply chains may see increased demand for active ingredients (API) for these drugs. No direct margin squeeze or scarcity for a single company is specified; the mechanism is broad public health and consumer staples demand shift.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources β not direct quotes from the publisher.
- Iran: medication prices rose by 400% amid war.
- Lebanon: demand for sedatives surged 300% since conflict began.
- Cuba: GDP contraction 17% since 2019, prescription drug use increased.
- Russia: antidepressant sales nearly tripled since 2019, +36% after failed peace talks in 2024.
- Antidepressants and sleeping pills dispensed without prescriptions in Iran.
Sustained inflation and FX weakness erode purchasing power and increase import costs for EM pharma, leading to a 2-5% cost increase.
Sign in to see all sector verdicts, full thesis and counter-argument debate.
Sector impact at a glance
- EM_MARKETSmid
- EM_MARKETSshort
Related stories

foreignpolicy.com
eu sanctions russia abductions ukraine children
economictimes.indiatimes.com
petrol diesel price hike rs 3 per litre india food inflation retail growth iran war impact rbi crude oil

rte.ie
1573272 warsh confirmed as fed chair as bank faces trump assault
straitstimes.com
kevin warsh confirmed as fed chair as central bank faces trump assault
finance.yahoo.com